Yahoo! Finance: PIKAMAB Secures Critical Patent Rights to Develop Theragnostic Product, Lupus Therasight

Source: Uinta County News

Menlo Park : CA : USA | about 1 month ago

0 0

Secures Critical Patent Rights to Develop Theragnostic Product, Lupus Therasight U.S...Lupus Therasight TM , a novel theragnostic product that will eventually help guide the drug development process and patient treatment protocols in the areas of lupus and lupus nephritis. “We are incredibly...

Reach
Credibility

More News From: Menlo Park : CA : USA

Related Allvoices Contributions

Off-year elections will test Democrats' influence

By: BiodunIginla

Tuesday, November 3, 2009 Advanced news search Preferences

about 1 month ago
Cancer research: an endless war?

By: DrMoskowitz

Cancer research: another endless war? America’s longest war, the current conflict in Afghanistan, now in its eighth year, has cost far fewer lives and dollars than our country’s nearly forty year-long War on Cancer, begun by President Nixon in 1970. Both still seem to have no end in sight. The latest strategy in ...

27 days ago
International Board of Human Rights Watch Meets in New Delhi for First ...

By: chnarendra

India's global leadership on human rights is increasingly necessary to counteract the negative role played by other powerful states, Human Rights Watch said today in holding its first meeting in India of its international board of directors. With India's powerful democratic traditions, strong courts, and active civil society, Human Rights ...

about 1 month ago
Joint Letter on Defamation Case against Usman Hamid of KontraS ...

By: etan009

Joint Letter on Defamation Case against Usman Hamid of KontraS Secretary of State Hillary Rodham Clinton U.S. Department of State 2201 C St., N.W. Washington, DC 20520 November 23, 2009 Dear Secretary Clinton, We are non-governmental organizations long concerned with human rights and ...

12 days ago
- 1
- 2
- >

News Stories

1-Star Stocks Poised to Plunge: Human Genome Sciences?

News Source: The Motley Fool | about 1 month ago

Human Genome believe the stock will underperform the S&P 500 going forward...A few months ago, bkwfool seemed skeptical over the company's lupus drug results: Hey, there has been lupus in my own family, so I know what a nasty disease it is. However,...
Yahoo! Finance: PIKAMAB Secures Critical Patent Rights to Develop ...

News Source: Uinta County News | about 1 month ago

Secures Critical Patent Rights to Develop Theragnostic Product, Lupus Therasight U.S...Lupus Therasight TM , a novel theragnostic product that will eventually help guide the drug development process and patient treatment protocols in the areas of...